BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33381172)

  • 1. The Correlation between Time in Range and Diabetic Microvascular Complications Utilizing Information Management Platform.
    Sheng X; Xiong GH; Yu PF; Liu JP
    Int J Endocrinol; 2020; 2020():8879085. PubMed ID: 33381172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation Between Blood Glucose Indexes Generated by the Flash Glucose Monitoring System and Diabetic Vascular Complications.
    Sheng X; Li T; Hu Y; Xiong CS; Hu L
    Diabetes Metab Syndr Obes; 2023; 16():2447-2456. PubMed ID: 37608851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Retrospective Study on the Time in Range of Blood Glucose and Type 2 Diabetic Peripheral Neuropathy.
    Li M; Wu K; Chang J; Jiang WC
    Biomed Res Int; 2022; 2022():2743679. PubMed ID: 35937384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study.
    De Meulemeester J; Charleer S; Visser MM; De Block C; Mathieu C; Gillard P
    Diabetologia; 2024 May; ():. PubMed ID: 38787436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review.
    Raj R; Mishra R; Jha N; Joshi V; Correa R; Kern PA
    BMJ Open Diabetes Res Care; 2022 Jan; 10(1):. PubMed ID: 34980591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The appropriate cut-off point of time in range (TIR) for evaluating glucose control in type 2 diabetes mellitus].
    Dai DJ; Lu JY; Zhang L; Shen Y; Mo YF; Lu W; Zhu W; Bao YQ; Zhou J
    Zhonghua Yi Xue Za Zhi; 2020 Oct; 100(38):2990-2996. PubMed ID: 33086449
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease.
    Mayeda L; Katz R; Ahmad I; Bansal N; Batacchi Z; Hirsch IB; Robinson N; Trence DL; Zelnick L; de Boer IH
    BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c.
    Xu F; Zhao LH; Su JB; Chen T; Wang XQ; Chen JF; Wu G; Jin Y; Wang XH
    Diabetol Metab Syndr; 2014; 6(1):139. PubMed ID: 25530811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Factors Related to Type 2 Diabetic Peripheral Neuropathy Based on Flash Glucose Monitoring System.
    Ma Q
    Med Sci Monit; 2023 Jun; 29():e939157. PubMed ID: 37287214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of serum vitamin D levels with diabetic microvascular complications in patients with type 2 diabetes mellitus.
    Zhao WJ; Xia XY; Yin J
    Chin Med J (Engl); 2021 Feb; 134(7):814-820. PubMed ID: 33538508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.
    Lv WS; Sun RX; Gao YY; Wen JP; Pan RF; Li L; Wang J; Xian YX; Cao CX; Zheng M
    World J Gastroenterol; 2013 May; 19(20):3134-42. PubMed ID: 23716995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Thyroid Hormone Levels with Microvascular Complications in Euthyroid Type 2 Diabetes Mellitus Patients.
    Hu Y; Hu Z; Tang W; Liu W; Wu X; Pan C
    Diabetes Metab Syndr Obes; 2022; 15():2467-2477. PubMed ID: 35982763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.
    Lu J; Ma X; Zhou J; Zhang L; Mo Y; Ying L; Lu W; Zhu W; Bao Y; Vigersky RA; Jia W
    Diabetes Care; 2018 Nov; 41(11):2370-2376. PubMed ID: 30201847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time in range, especially overnight time in range, is associated with sudomotor dysfunction in patients with type 1 diabetes.
    Feng ZQ; Guo QY; Wang W; Yuan YY; Jin XG; Zhou H; Liu J; Lei HY; Yang XY; Liu J; Lu B; Shao JQ; Gu P
    Diabetol Metab Syndr; 2021 Oct; 13(1):119. PubMed ID: 34702362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T1DMicro: A Clinical Risk Calculator for Type 1 Diabetes Related Microvascular Complications.
    Tran PMH; Kim E; Tran LKH; Khaled BS; Hopkins D; Gardiner M; Bryant J; Bernard R; Morgan J; Bode B; Reed JC; She JX; Purohit S
    Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of vitamin D deficiency with diabetic peripheral neuropathy and diabetic nephropathy in Tianjin, China.
    Fan L; Zhang Y; Zhu J; Song Y; Lin J
    Asia Pac J Clin Nutr; 2018; 27(3):599-606. PubMed ID: 29737807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of glycaemic variability evaluated by continuous glucose monitoring with diabetic peripheral neuropathy in type 2 diabetic patients.
    Hu YM; Zhao LH; Zhang XL; Cai HL; Huang HY; Xu F; Chen T; Wang XQ; Guo AS; Li JA; Su JB
    Endocrine; 2018 May; 60(2):292-300. PubMed ID: 29411305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous glucose monitoring defined time-in-range is associated with sudomotor dysfunction in type 2 diabetes.
    Guo QY; Lu B; Guo ZH; Feng ZQ; Yuan YY; Jin XG; Zang P; Gu P; Shao JQ
    World J Diabetes; 2020 Nov; 11(11):489-500. PubMed ID: 33269061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time in blood glucose range 70 to 180 mg/dL and survival rate in critically ill patients: A retrospective cohort study.
    Naraba H; Goto T; Shirakawa T; Sonoo T; Kanda N; Nakano H; Takahashi Y; Hashimoto H; Nakamura K
    PLoS One; 2021; 16(5):e0252158. PubMed ID: 34043681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.